李 亭儀

Medicine & Life Sciences

1. Peroxisome Proliferator-Activated Receptors 100%
2. Cardiac Myocytes 80%
3. Diabetes Mellitus 70%
4. Diabetic Cardiomyopathies 67%
5. Calcium 55%
6. Histone Deacetylases 52%
7. Type 2 Diabetes Mellitus 45%
8. Receptor for Advanced Glycation End Products 41%
9. Homeostasis 39%
10. Patient Education 37%
11. Calcitriol 36%
12. Inbred SHR Rats 32%
13. Streptozocin 32%
14. Pulmonary Veins 31%
15. Inflammation 30%
16. Tumor Necrosis Factor-alpha 28%
17. empagliflozin 27%
18. Sarcoplasmic Reticulum 27%
19. Adrenal Insufficiency 25%
20. Sitagliptin Phosphate 25%
21. Glucose 25%
22. 3-(1-benzenesulfonyl-1H-indol-5-yl)-N-hydroxyacrylamide 25%
23. Vitamin D 25%
24. fibroblast growth factor 23 25%
25. Rosiglitazone 24%
26. Calcium-Transporting ATPases 23%
27. Hypertension 23%
28. Calcitriol Receptors 21%
29. Hydrocortisone 21%
30. Corticotropin-Releasing Hormone 20%
31. Hypoglycemic Agents 20%
32. Atrial Fibrillation 20%
33. Heart 19%
34. Receptor, Fibroblast Growth Factor, Type 1 18%
35. Fine Needle Biopsy 18%
36. Atrial Remodeling 17%
37. Combined Pituitary Hormone Deficiency 17%
38. Fasting 17%
39. Muscle Cells 17%
40. Adrenocorticotropic Hormone 16%
41. Sarcopenia 16%
42. Inbred WKY Rats 15%
43. Pharmacy Education 15%
44. Heart Atria 15%
45. Sodium 15%
46. Proteins 14%
47. Comorbidity 14%
48. Methylation 14%
49. Fatty Acids 14%
50. Stiff-Person Syndrome 14%